Top compounds associated with response to CLEC2L


Feature Type Standardized
Nominal ANOVA
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.066 0.06
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.052 0.06
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.065 0.06
mRNA CAL-101 CTRPv2 pan-cancer AAC -0.066 0.07
mRNA Bortezomib GDSC1000 pan-cancer AAC 0.087 0.07
mRNA BRD-K34222889 CTRPv2 pan-cancer AAC -0.057 0.07
mRNA CGP-60474 GDSC1000 pan-cancer AAC 0.091 0.07
mRNA chlorambucil CTRPv2 pan-cancer AAC -0.056 0.07
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.066 0.07
mRNA JW-7-24-1 GDSC1000 pan-cancer AAC -0.053 0.07
Download CSV